Skip to main content
. 2019 Feb 26;39(Suppl 1):1–151. doi: 10.1007/s10875-019-00597-5
M/F Age at onset (years) ALPS/ALPS-like Symptoms Genetic mutation Defective lymphocyte apoptosis sFAS-L (>200 pg/ml) IL-10 (>20 pg/ml) IL-18 (>500 pg/ml) Vit B12 (n.r. 191 - 663 pg/ml) IgG (mg/dl) Family history DNT (>1.5% of total lymph) B220+ DNT (>60%) CD3+CD25+ / CD3+HLADR+ ratio (<1%) CD27+ (<15%)
P1 F 12 ALPS-like + Autoimmunity

- CASP10 - Leu522lle

- CASP8 - Met1Thr (Homozygosis)

No 0 4 365 482 1407 Neg 1.7 22 0.3 84.3
P2 M 11 ALPS-like Trilinear cytopenia + Autoimmunity + LP

- CASP10 - Leu522lle

- TNFRSF13C – His159Tyr

- TNFRSF13C – Pro21Arg

No 0 3 660 356 820 Neg 4 70.6 0.1 4.5
P3 F 9 ALPS-like monolinear cytopenia + LP - CASP10 – Val410lle Yes (100%) 0 1,1 550 1014 1076 Neg 1.2 46 1.3 0.3
P4 F 5 ALPS P monolinear cytopenia + LP - CASP10 – Tyr446Cys No 0 <1 1050 466 1094 Neg 2.3 92 0.2 15.6
P5 M 3 No monolinear cytopenia + RRI + Recurrent skin abscesse - CASP10 – Val410lle ND 0 <1 75 699 1154 Neg 1.1 61.7 0.9 12.4
P6 M 2 ALPS Asthenia + LP + RI + Arthromyalgia - CASP10 – I406L No 0 <1 500 583 1062 Neg 3.9 57 0.7 23.6